PMV Pharmaceuticals, Inc. (PMVP)
CIK 1699382 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for PMV Pharmaceuticals, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 2, 2026 | 8-K | 0001193125-26-378838 |
| Sep 2, 2026 | 424B5 | 0001193125-26-378780 |
| Aug 31, 2026 | 424B3 | 0001193125-26-377000 |
| Aug 31, 2026 | 8-K | 0001193125-26-376723 |
| Aug 31, 2026 | 424B5 | 0001193125-26-376860 |
| Aug 14, 2026 | 10-Q | 0001193125-26-350448 |
| Aug 14, 2026 | 8-K | 0001193125-26-350445 |
| Jul 28, 2026 | SCHEDULE 13G/A | 0001214659-26-009110 |
| Jul 10, 2026 | SCHEDULE 13G/A | 0001172661-26-002568 |
| Jun 5, 2026 | 4 | 0001329959-26-000002 |
| Jun 5, 2026 | 4 | 0001797209-26-000002 |
| Jun 5, 2026 | 4 | 0001644348-26-000003 |
| Jun 5, 2026 | 4 | 0001124164-26-000002 |
| Jun 5, 2026 | 8-K | 0001193125-26-258466 |
| Jun 5, 2026 | 4 | 0001579824-26-000003 |
| May 15, 2026 | SCHEDULE 13G/A | 0001012975-26-000440 |
| May 12, 2026 | 8-K | 0001193125-26-218225 |
| May 12, 2026 | 10-Q | 0001193125-26-218227 |
| May 4, 2026 | SCHEDULE 13G/A | 0001214659-26-005496 |
| Apr 22, 2026 | ARS | 0001140361-26-016040 |
| Apr 22, 2026 | DEF 14A | 0001140361-26-016038 |
| Apr 22, 2026 | DEFA14A | 0001140361-26-016039 |
| Mar 9, 2026 | 4 | 0001341642-26-000002 |
| Mar 9, 2026 | 4 | 0001825192-26-000002 |
| Mar 9, 2026 | 4 | 0001613482-26-000002 |